Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.7 USD | +3.96% |
|
+7.01% | +87.16% |
12:00am | Praxis Precision Medicines, Inc.(NasdaqGS:PRAX) added to S&P Biotechnology Select Industry Index | CI |
06-18 | Guggenheim Initiates Praxis Precision Medicines With Buy Rating, $155 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+87.16% | 713M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+35.20% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- PRAX Stock
- News Praxis Precision Medicines, Inc.
- Praxis Precision Medicines Plans Public Equity Offering